From: Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients
Par. | Test 1 | Test 2 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | 1 year time-point | 3 year time-point |  | 1 year time-point | 3 year time-point |  | ||||||||
 | Med | 25 th | 75 th | Med | 25 th | 75 th | P | Med | 25 th | 75 th | Med | 25 th | 75 th | P |
BD | 5.15 | 4.30 | 5.77 | 4.92 | 3.82 | 5.62 | <0.01 | 4.99 | 4.26 | 5.23 | 4.67 | 4.19 | 5.13 | 0.55 |
MA | 5.05 | 4.11 | 5.57 | 4.71 | 3.71 | 5.50 | <0.01 | 4.65 | 4.05 | 4.97 | 4.36 | 3.88 | 4.90 | 0.48 |
RA | 0.17 | 0.06 | 0.28 | 0.11 | 0.04 | 0.22 | 0.24 | 0.24 | 0.05 | 0.34 | 0.24 | 0.05 | 0.43 | 0.53 |
PC | 0.97 | 0.95 | 0.99 | 0.97 | 0.96 | 0.99 | 0.68 | 0.95 | 0.93 | 0.99 | 0.95 | 0.90 | 0.99 | 0.54 |
RT | 0.62 | 0.20 | 1.06 | 0.72 | 0.52 | 1.08 | 0.30 | 1.04 | 0.56 | 1.50 | 1.10 | 0.70 | 1.34 | 0.80 |
CV | 0.26 | 0.13 | 0.34 | 0.15 | 0.07 | 0.26 | 0.38 | 0.20 | 0.09 | 0.34 | 0.21 | 0.05 | 0.44 | 0.89 |